For research and educational purposes only. Not medical advice.
Lion's mane Reference
Educational, not medical advice reference for Lion's mane: Nootropic, Cognitive; regulatory status, evidence posture, source review, and schedule notes. Also…
Reference summary
Small Japanese and Western clinical trials in mild cognitive impairment and depression. Effect sizes are modest with 8-16 week onset.
- Categories
- Nootropic, Cognitive
- Aliases
- Hericium erinaceus, Yamabushitake
- Evidence posture
- human — Sold as a dietary supplement, not as an FDA-approved drug. Effects on cognition or NGF pathways are reported across small trials with mixed quality. Not a treatment.
- Regulatory status
- No FDA-approved lion's mane drug label. Sold as a dietary supplement / functional food.
- Content review status
- research reference